大鼠中脑腹侧被盖区在睡眠－觉醒调节中的作用

本实验在３１只清醒自由行动的雄性ＳＤ大鼠进行。结果如下：（１）双侧中脑腹侧被盖区（ＶＴＡ）微量注射３．３ｎｍｏｌ溴隐亭后第２—３ｈ觉醒时间显著增加（Ｐ＜０．０１）;６．６ｎｍｏｌ溴隐亭有类似效果;０．６６和１．３３ｎｍｏｌ溴隐亭无明显作用。（２）同样方法ＶＴＡ微量注射２ｎｍｏｌ和４ｎｍｏｌＳＣＨ２３３９０后第２—３ｈ觉醒时间明显减少（分别为Ｐ＜０．０１和Ｐ＜０．０５）,但注射３．４ｎｍｏｌ舒必利则无效。（３）红藻氨酸（０．３μｇ）双侧ＶＴＡ注后一周,大鼠白天觉醒减少,夜间无明显变化。以上结果表明溴隐亭微量注射到ＶＴＡ可能通过Ｄ１受体使多巴胺神经元活动增加而产生致觉醒作用;另外ＶＴＡ中ＤＡ神经元对于维持日间的觉醒可能有紧张性作用。     

Neuroprotective Mechanisms of Antiparkinsonian Dopamine D2-Receptor Subfamily Agonists

Numerous studies have shown that endogenous and/or environmental neurotoxins and oxidative stress may participate in the pathogenesis of Parkinson's disease (PD), but the detailed mechanisms are still unclear. While dopamine (DA) replacement therapy with L-DOPA (levodopa) improves PD symptoms, it does not inhibit the degeneration of DA neurons in the substantia nigra. Recently, bromocriptine, pramipexole and several other agonists of the dopamine D₂-receptor subfamily (including D₂, D₃ and D₄-subtypes) have been shown to have neuroprotective effects in parkinsonian models in vitro and in vivo. Their neuroprotective effects may be mediated directly and/or indirectly by antioxidant effects, mitochondrial stabilization or induction of the antiapoptotic Bcl-2 family.     

Dopamine receptor agonist bromocriptine restrains the follicular development,hatchling success and puberty in Gambusia affinis

The present investigation was conducted to determine the influence of dopamine (DA) receptor agonist bromocriptine (BRO) on reproduction and onset of puberty in the viviparous fish Gambusia affinis. In the first experiment, the mean number of stage I and II follicles (previtellogenic) in 0.8 or 5 mg BRO treated fish did not show significant difference compared to those of experimental controls, whereas the mean number of stage III follicles were significantly lower in 5 mg BRO treated fish compared to experimental controls. However, treatment of 0.8 or 5 mg BRO resulted in significantly lower numbers of stage IV (early vitellogenic) and V (late vitellogenic) follicles compared to those of experimental controls. There was decrease in the percent occurrence of pregnancy and different stages of embryos in BRO treated fish compared with the experimental controls. Concomitant with this, sparsely distributed gonadotropin releasing hormone immunoreactive (GnRH‐ir) fibres were observed in the proximal pars distalis (PPD) region of the pituitary gland in BRO treated fish compared to those of dense accumulations of these fibres in the PPD region of the pituitary gland in experimental controls. In the second experiment, exposure of juveniles (25 DPH) to same doses of BRO for 45 days resulted in complete absence of vitellogenic follicles and presence of few GnRH‐ir fibres in 5 mg BRO treated juvenile in contrast to presence of vitellogenic follicles and dense aggregation of GnRH fibres in treatment controls. Overall, the results of the present investigation suggest that DA affects ovarian follicular and embryonic development and onset of puberty in viviparous species.     

Structural insights into the human D1 and D2 dopamine receptor signaling complexes

1. Download : Download high-res image (263KB)
2. Download : Download full-size image

     

Effects of bromocriptine on cyclic-GMP contents of some endocrine glands and liver in rats

Cyclic GMP contents of the thyroid gland and ovary were significantly increased in response to single and multiple treatments of bromocriptine, an effect which was antagonized by sulpiride. Liver and adrenocortical cyclic GMP levels have not been changed by bromocriptine although sulpiride alone induced a significant reduction. The data may indicate the presence of D₂ receptors in ovary and thyroid gland that are related to cyclic GMP.     

中脑腹侧被盖区微量注射溴隐亭对伏隔核DOPAC含量的影响

本工作在戊巴比妥钠麻醉的SD雄性大鼠上进行。结果表明:左侧腹侧被盖区(VTA)微量注射多巴胺(DA)受体激动剂溴隐亭(2.5μg/0.5μl,n=5)后,用微分脉冲伏安法(DPV)测定同侧伏隔核中多巴胺代谢产物——3、4双羟苯乙酸(DOPAC),峰值明显增高,注后50 min达到对照值的128％(P<0.01),注后80 min达到最高峰,为对照值的143％(P<0.01),作用的持续时间约2 h,在注后180 min恢复到对照值的111％(P>0.05)。左侧VTA预先微量注射SCH23390——一种高选择性的D_1受体阻断剂(2nmol/0.5μl,n=4).40min后再微量注射溴隐亭(2.5μg/0.5μl),同侧伏隔核中DOPAC氧化峰不再增高。结果提示:VTA微量注射溴隐亭可致中脑边缘多巴胺神经元活动增加,而这种增加作用可能是通过D_1受体中介的。     

Role of cyclic AMP in the action of dopaminergic D2 receptors of some endocrine glands in rats

Short-term and long-term effects of bromocriptine mesylate (10 mg/kg i.p.) on cyclic AMP contents of the liver and some endocrine glands have been investigated in the presence and absence of sulpiride (10 mg/kg i.p.). Results revealed that bromocriptine caused significant elevations in the cyclic AMP contents of the liver and reduction in its adrenocortical content. Bromocriptine effect on the adrenal cortex was antagonized by sulpiride, whereas its effect on the liver was not changed. Bromocriptine did not change the, cyclic AMP content in the thyroid gland or the ovary.     

Role of Na+/K+-stimulated adenosine triphosphatase in the action of dopaminergic-D2 receptors of the liver in rats

The dopamine receptor agonist, bromocriptine, in a dose of 10 mg/kg i.p. for 14 days, in rats caused a significant increase in liver Na⁺/K⁺-ATPase activity, whereas sulpiride, a dopamine receptor antagonist, in a dose of 10 mg/kg, i.p. for 14 days, in rats, caused a significant decrease in liver Na⁺/K⁺-ATPase activity. Injection of bromocriptine and sulpiride simultaneously in a group of rats, under the same conditions and using the same doses caused a complete block of both stimulatory activity of bromocriptine and inhibitory activity of sulpiride on liver Na⁺/K⁺-ATPase activity. It is suggested that Na⁺/K⁺-ATPase may have a role in the action of dopaminergic-D₂ receptors.